William Park, MD
Foot and Ankle Surgery · Daphne, ALNPI 1780642710
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 29 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 7 manufacturers reported payments, led by DJO, LLC at 49.3% of the total. 2025 is the largest year on record at $384, more than ten times the $14 reported in 2019. That places this record below the midpoint for foot and ankle surgery clinicians in AL, where the typical reported total is $4,589.
Across 29 payments — averaging $32.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- DJO, LLC$469
- Johnson & Johnson$153
- Bioventus LLC$129
- Stryker$115
- Smith+Nephew$41
- Kerecis Limited$25
- plus $19 from 1 others
What the payments were for
- Food & beverage$950100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| DJO, LLC | 14 | $469 |
| Johnson & Johnson | 4 | $153 |
| Bioventus LLC | 4 | $129 |
| Stryker | 4 | $115 |
| Smith+Nephew | 1 | $41 |
| Kerecis Limited | 1 | $25 |
| Assertio Therapeutics, Inc. | 1 | $19 |
How this compares
$950 in reported general payments places this provider in the 20th percentile of 40 foot and ankle surgery providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 90 | $1,124 |
| Diclofenac Sodium | 48 | $782 |
| Meloxicam | 200 | $469 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 58 | $375 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 85 | $325 |
| Methylprednisolone | 30 | $185 |
| Tramadol Hcl | 44 | $183 |
| Doxycycline Hyclate | 22 | $132 |
| Gabapentin | 11 | $93 |
Paid to pharmacies, not to this prescriber.
Other foot and ankle surgery in Daphne
- Norman WaldropBirmingham$3.6M
- Justin DaigreDecatur$372K
- John KirchnerHoover$84K
- Jefferson SabatiniHuntsville$56K
- Matthew DeorioHuntsville$49K
- Patricia AnteroTuscaloosa$35K
- Ashish ShahBirmingham$28K
- Alfred RicciMontgomery$25K
- Swapnil SinghBirmingham$14K
- Derek KlavasMobile$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.